O&G Vivas · Gynaecological health — benign gynaecology
Fibroid surgery and morcellation — structured oral station (12 minutes)
FRANZCOG oral-format station on fibroid surgery: candidate justifies the FIGO-type-to-route mapping, defends a contained-morcellation plan under RANZCOG C-Gyn 33, and counsels on UAE durability and the fertility-preservation boundary. Scored against the eight published RANZCOG oral domains.
On this page & tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport; respect; communication skills. You are marked on how you behave, not only what you know. [1]
Reveal the examiner script and model responses
Opening prompt — "Justify the operative plan"
- "The FIGO type 1 submucosal fibroid goes to hysteroscopic myomectomy — cavity access, controls the bleeding, improves fertility, uterus-sparing. The three FIGO type 4 intramural fibroids go to laparoscopic myomectomy with multi-layer closure."
- "The route follows the FIGO type: 0 to 2 hysteroscopic, 3 to 7 laparoscopic or open, hysterectomy when the family is complete. She is family-incomplete, so uterus-sparing throughout."[1]
Probe 1 — "How will you get the specimen out, and what governs that?"
- "By power morcellation with an in-bag containment system. RANZCOG C-Gyn 33 governs this: morcellation only with no suspicion of malignancy (including atypical endometrial hyperplasia), an in-bag containment system, and a credentialed operator — generally AGES-RANZCOG Level 5 and above."[1]
Probe 2 — "She is 38 and wants another baby. Is there no risk?"
- "There is no reliable pre-operative test for leiomyosarcoma — incidence 0.36 to 1.8 per 100,000 woman-years, and the risk of diagnosing LMS after presumed-fibroid surgery is 0.01 to 0.08 per cent. I exclude suspicion clinically and on MRI, use contained extraction, and consent her on the occult-sarcoma risk."[1]
Probe 3 — "A colleague suggests UAE instead. Do you agree?"
- "UAE is uterus-sparing with faster recovery — the REST trial showed a 1-day versus 5-day stay. But about a third of women having UAE need a hysterectomy within ten years (EMMY 35 per cent), and effects on fertility and pregnancy are uncertain. RANZCOG does not recommend routine UAE in young patients wishing to conceive. For her, myomectomy is the fertility-preserving choice; UAE would be a trial-setting discussion only."[2][3][4]
Probe 4 — "She asks what the operation means for her next pregnancy"
This is a scored communication domain — demonstrate it out loud: [1]
- "There is a real risk of uterine rupture in a future pregnancy after myomectomy, and we will discuss the safest way for you to deliver. I will use meticulous multi-layer closure to minimise scarring, and I want you to tell your obstetric team about this operation in any future pregnancy."
- Offer a clear plan, a timeline, and a named contact between visits.[1]
Probe 5 — "How would your plan change if she were 58 and postmenopausal with a rapidly growing fibroid?"
- "A rapidly growing fibroid postmenopause is leiomyosarcoma until proven otherwise. I would arrange MRI with diffusion-weighted imaging and endometrial sampling, plan en-bloc removal, avoid morcellation, and involve gynaecological oncology. The contained-morcellation plan is only for the no-suspicion case."[1]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References4Show ledgerHide ledger
- [1]American College of Obstetricians and Gynecologists (ACOG) Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228 Obstet Gynecol, 2021.PMID 34011888
- [2]de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial Am J Obstet Gynecol, 2016.PMID 27393268
- [3]Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids N Engl J Med, 2007.PMID 17251532
- [4]Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility Cochrane Database Syst Rev, 2020.PMID 31995657